Sex‐dependent effects of liraglutide on growth hormone secretion occur independently of GLP ‐1 receptor expression in GHRH neurons
Journal of Neuroendocrinology · 2026-11 · 38 (11)
DOI: 10.1111/jne.70330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 17.11.2026. Verfasst von Luis F. Almeida und 4 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Glucagon‐like peptide‐1 receptor (GLP1R) agonists are widely used to treat diabetes mellitus and obesity. Growth hormone (GH)‐releasing hormone (GHRH) neurons in the arcuate nucleus of the hypothalamus express GLP1R; however, the functional relevance of GLP1R signaling in these neurons and the effects of GLP1R agonists on GH secretion remain unclear. Mice with GLP1R ablation in GHRH‐expressing cells were examined. Loss of GLP1R signaling in GHRH neurons did not affect body weight, body composition, energy expenditure, locomotor activity, glycemia, or glucose tolerance in male or female mice, although GHRH ∆GLP1R males showed a trend toward lower food intake. Acute liraglutide administration in male mice did not stimulate GH secretion. GLP1R ablation in GHRH neurons did not alter liraglutide‐induced weight loss or improvements in glucose homeostasis in either sex. Notably, liraglutide‐treated males regained body weight after 5 days of treatment, whereas weight loss was sustained in females. Liraglutide also produced sex‐dependent effects on GH secretion: in males, it reduced pulsatile GH secretion, whereas in females, liraglutide treatment increased total GH secretion, pulse frequency, basal GH secretion, and reduced IGF‐1 levels. GHRH ∆GLP1R mice showed no alterations in GH secretion, except for an increased GH pulse frequency in females. These findings demonstrate that GLP1R expression in GHRH neurons is not required for the metabolic or endocrine effects of liraglutide, including its actions on food intake, body weight, glucose homeostasis, and GH secretion. Instead, the effects of GLP1R agonists on GH dynamics are possibly secondary to sex‐specific treatment‐induced changes in body weight.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Almeida, L. F., Souza, G. O. D., Vicente, V. A. N., Martins, M. G., & Donato, J. (2026). Sex‐dependent effects of liraglutide on growth hormone secretion occur independently of GLP ‐1 receptor expression in GHRH neurons. Journal of Neuroendocrinology, 38(11). https://doi.org/10.1111/jne.70330
Vancouver
Almeida LF, Souza GOD, Vicente VAN, Martins MG, Donato J. Sex‐dependent effects of liraglutide on growth hormone secretion occur independently of GLP ‐1 receptor expression in GHRH neurons. Journal of Neuroendocrinology. 2026;38(11). doi:10.1111/jne.70330
BibTeX
@article{Almeida2026,
author = {Almeida, Luis F. and Souza, Gabriel O. de and Vicente, Vanielle A. N. and Martins, Marina G. and Donato, Jose},
title = {Sex‐dependent effects of liraglutide on growth hormone secretion occur independently of GLP ‐1 receptor expression in GHRH neurons},
journal = {Journal of Neuroendocrinology},
year = {2026},
volume = {38},
number = {11},
doi = {10.1111/jne.70330}
}
EUVIMED